# scPharmaceuticals Inc. (SCPH)

Source: https://www.quantisnow.com/company/SCPH
Generated: 2026-11-09T21:35:46.918Z

- Ticker: SCPH
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2017
- Website: scpharmaceuticals.com

## About

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of proprietary buffered formulation of furosemide, which is delivered through the SmartDose drug delivery system for treatment of congestion in decompensated heart failure patients. Its product pipeline also includes scCeftriaxone, an antibiotic to treat infections caused by gram-positive and gram-negative organisms; and scCarbapenem program, an antibiotic for treating infections caused by gram-negative organisms. The company has a development agreement with West Pharmaceutical Services, Inc. to incorporate SmartDose drug delivery system with Furoscix. scPharmaceuticals Inc. was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

## Latest SCPH news and filings

- 2025-11-20 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-scpharmaceuticals-inc-6287854)
- 2025-11-20 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-scpharmaceuticals-inc-6287845)
- 2025-11-20 05:15 UTC [SEC Form EFFECT] [SEC Form EFFECT filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-effect-filed-by-scpharmaceuticals-inc-6287842)
- 2025-11-14 18:30 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-scpharmaceuticals-inc-6279919)
- 2025-11-12 19:52 UTC [SEC Form SCHEDULE 13G filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-scpharmaceuticals-inc-6273958)
- 2025-11-10 13:41 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-scpharmaceuticals-inc-6269839)
- 2025-10-17 19:40 UTC [SEC Form 15-12G filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-15-12g-filed-by-scpharmaceuticals-inc-6236814)
- 2025-10-14 20:10 UTC [SEC Form SCHEDULE 13G filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-scpharmaceuticals-inc-6232358)
- 2025-10-08 21:02 UTC [Amendment: SEC Form SCHEDULE 13G/A filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13ga-filed-by-scpharmaceuticals-inc-6227880)
- 2025-10-07 20:30 UTC [SEC Form 4] [Director Schaeffer Leonard D closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-schaeffer-leonard-d-closing-all-direct-ownership-in-the-6226418)
- 2025-10-07 20:30 UTC [SEC Form 4] [CFO and Treasurer Nokes Rachael returned 125,675 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/cfo-and-treasurer-nokes-rachael-returned-125675-shares-to-the-6226417)
- 2025-10-07 20:30 UTC [SEC Form 4] [SEC Form 4 filed by Director Baylor-Henry Minnie](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-baylor-henry-minnie-6226416)
- 2025-10-07 20:30 UTC [SEC Form 4] [SEC Form 4 filed by Director Hudson Frederick M.](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-hudson-frederick-m-6226414)
- 2025-10-07 20:30 UTC [SEC Form 4] [President and CEO Tucker John H returned 318,502 shares to the company, closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/president-and-ceo-tucker-john-h-returned-318502-shares-to-6226413)
- 2025-10-07 20:30 UTC [SEC Form 4] [SEC Form 4 filed by Director Veitinger Klaus R Dr](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-veitinger-klaus-r-dr-6226412)
- 2025-10-07 20:30 UTC [SEC Form 4] [SEC Form 4 filed by Director Abraham William Tober](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-abraham-william-tober-6226411)
- 2025-10-07 20:30 UTC [SEC Form 4] [SEC Form 4 filed by Director Bonstein Sara](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-bonstein-sara-6226407)
- 2025-10-07 20:30 UTC [SEC Form 4] [SEC Form 4 filed by Director Agger Mette Kirstine](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-agger-mette-kirstine-6226405)
- 2025-10-07 20:30 UTC [SEC Form 4] [Director Khattar Jack A. closing all direct ownership in the company (SEC Form 4)](https://www.quantisnow.com/insight/director-khattar-jack-a-closing-all-direct-ownership-in-the-6226402)
- 2025-10-07 20:22 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-scpharmaceuticals-inc-6226358)
- 2025-10-07 20:20 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-scpharmaceuticals-inc-6226352)
- 2025-10-07 20:19 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-scpharmaceuticals-inc-6226348)
- 2025-10-07 20:17 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-scpharmaceuticals-inc-6226342)
- 2025-10-07 20:15 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-scpharmaceuticals-inc-6226326)
- 2025-10-07 20:14 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-scpharmaceuticals-inc-6226289)
- 2025-10-07 20:12 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-scpharmaceuticals-inc-6226278)
- 2025-10-07 20:11 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-scpharmaceuticals-inc-6226271)
- 2025-10-07 20:09 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-scpharmaceuticals-inc-6226251)
- 2025-10-07 20:07 UTC [SEC Form S-8 POS] [SEC Form S-8 POS filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-s-8-pos-filed-by-scpharmaceuticals-inc-6226230)
- 2025-10-07 20:04 UTC [SEC Form POS AM filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-scpharmaceuticals-inc-6226156)
- 2025-10-07 20:02 UTC [SEC Form POS AM filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-scpharmaceuticals-inc-6226150)
- 2025-10-07 20:01 UTC [SEC Form POS AM filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-pos-am-filed-by-scpharmaceuticals-inc-6226131)
- 2025-10-07 13:23 UTC [SEC Form 25-NSE filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/sec-form-25-nse-filed-by-scpharmaceuticals-inc-6225798)
- 2025-10-07 13:18 UTC [SEC Form 8-K] [scPharmaceuticals Inc. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Termination of a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update](https://www.quantisnow.com/insight/scpharmaceuticals-inc-filed-sec-form-8-k-completion-of-acquisition-or-6225786)
- 2025-10-07 13:14 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-scpharmaceuticals-inc-6225782)
- 2025-10-07 12:19 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-scpharmaceuticals-inc-6225580)
- 2025-09-30 20:09 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-scpharmaceuticals-inc-6216069)
- 2025-09-30 20:03 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-scpharmaceuticals-inc-6215986)
- 2025-09-29 20:11 UTC [SEC Schedule 14D-9] [Amendment: SEC Form SC 14D9/A filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-14d9a-filed-by-scpharmaceuticals-inc-6214475)
- 2025-09-29 20:01 UTC [SEC Schedule TOT] [Amendment: SEC Form SC TO-T/A filed by scPharmaceuticals Inc.](https://www.quantisnow.com/insight/amendment-sec-form-sc-to-ta-filed-by-scpharmaceuticals-inc-6214364)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/SCPH
- Earnings history: https://www.quantisnow.com/earnings/SCPH
- Dividend history: https://www.quantisnow.com/dividends/SCPH
- Insider transactions: https://www.quantisnow.com/insiders/SCPH
- Options chain: https://www.quantisnow.com/options/SCPH
- SEC 8-K filings only: https://www.quantisnow.com/company/SCPH/8-k
- RSS and alerts for SCPH: https://www.quantisnow.com/docs/rss-feeds.md